An international team of investigators today announced promising data from a trial of a novel antibiotic that could ...

New clinical trial results presented by TB Alliance at the Union World Conference on Lung Health show that the novel ...

Clinical trial results found that a new antibiotic candidate could shorten TB treatment from the standard 6 months to 8 weeks ...

A new TB drug, sorfequiline, shows promising results in a multinational trial, raising hopes for faster and simpler treatment ...

Early clinical trial results show that the new antibiotic sorfequiline, used in the SPaL regimen, demonstrated stronger ...

One of the deadliest infectious diseases can be difficult to treat because of drug-resistant strains. But with a new study, scientists from a group of institutions including Scripps Research in La ...

Tuberculosis (TB) is one of the world's most common infectious diseases. Although infection with the Mycobacterium ...

Experts warn that extensively drug-resistant tuberculosis is emerging as a ‘quietly growing monster’ that could undermine ...

Gauteng health authorities are making progress in starting RR-TB patients on treatment, but a new NICD report shows that many still face delays or are never traced after diagnosis.

Collaboration seeks to pull more sick children out of the shadows and into treatment for tuberculosis TB Alliance has announced a new partnership with the U.S. Fund for UNICEF that will dramatically ...